China Universal Asset Management »

Rocket Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Rocket Pharmaceuticals (RCKT) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Rocket Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Rocket Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rocket Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $468k 17k 26.94
2023-12-31 $312k 10k 29.97
2023-09-30 $42k 2.1k 20.49
2023-06-30 $21k 1.1k 19.87
2023-03-31 $18k 1.1k 17.13
2022-12-31 $15k 769 19.57
2022-09-30 $10k 618 16.18

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Rocket Pharmaceuticals

Wellington Management Company
BlackRock
Vanguard Group
Westfield Capital Management Company
Maverick Capital
T. Rowe Price Associates
Henderson Group
Citadel Advisors
Franklin Resources
Perceptive Advisors
Frazier Life Sciences Management
Geode Capital Management
Boxer Capital
Pictet Asset Management Holding SA
Logos Global Management

View all funds holding Rocket Pharmaceuticals